The Challenge of High Costs and Recalls
Despite its growth, the Drug Infusion System Market faces challenges, particularly regarding the high cost of advanced systems and the issue of device recalls. The initial investment for hospitals to purchase smart infusion pumps and integrate them into their existing IT infrastructure can be substantial. This can be a barrier to adoption, especially for smaller hospitals or those in developing economies with limited budgets.
Furthermore, infusion pumps have been subject to numerous recalls due to software glitches, battery failures, and other technical issues. These recalls, often issued by regulatory bodies like the FDA, highlight the critical importance of device safety and can damage a manufacturer's reputation. Addressing these challenges requires continuous investment in R&D to improve device reliability and a greater focus on quality control and post-market surveillance.